longbridge

Allogene Therapeutics

ALLO
0.83871.41% ( +0.0117 )
Closed: Nov 13, 16:00:00 (EDT)

Shareholders

All Shareholders

Shareholder Type

  • Institutions74.46%
  • VC/PE firms12.84%
  • Public and others7.17%
  • Individuals & Insiders5.53%

Major Shareholders

Major Shareholders Latest
Shareholder
BlackRock, Inc.
6.70%23.21M2.03%-6.94M
Frazier Life Sciences Management, LP
6.48%22.45M4.93%+18.65M
Pfizer Venture Investments LLC
6.36%22.03M0.02%+0
State Street Investment Management
4.71%16.33M0.80%-2.70M
Vanguard Capital Management, LLC
4.04%14.00M0.77%+5.99M
Sio Capital Management, LLC
3.85%13.32M--+13.32M
PRIMECAP Management Company
3.79%13.12M0.36%+4.74M
UBS Asset Management AG
3.09%10.70M2.21%+7.67M
FMR LLC
3.06%10.59M0.42%-1.41M
Citadel Advisors LLC
2.91%10.09M0.14%+3.29M
Two Sigma Investments, LP
2.25%7.78M0.05%+2.41M
Geode Capital Management, LLC
1.86%6.45M0.18%-602.53K
Arie BelldegrunCo-Founder & Executive Chairman
1.75%6.08M0.73%+0
The Goldman Sachs Group, Inc.
1.73%5.99M<0.01%+0
David ChangCo-Founder & Director
1.72%5.95M0.71%+0
Candriam, Société En Commandite Par Actions
1.57%5.42M0.31%+1.09M
GordonMD Global Investments LP
1.53%5.30M0.95%+3.87M
Aberdeen Group Plc
1.52%5.26M0.07%+257.93K
Marshall Wace LLP
1.47%5.10M0.06%+1.65M
Millennium Management LLC
1.40%4.84M0.04%+1.52M
© 2026 Longbridge｜Terms of ServicePrivacy Policy